4//SEC Filing
IMMUNE RESPONSE CORP 4
Accession 0001294002-05-000023
CIK 0000817785operating
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 6:25 PM ET
Size
5.6 KB
Accession
0001294002-05-000023
Insider Transaction Report
Form 4
THEOFAN GEORGIA
VP, Clinical Development
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2005-07-18+100,000→ 100,000 totalExercise: $0.74From: 2005-07-18Exp: 2015-07-18→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option is 25% vested on grant date. The remaining 75% will vest daily over a 2-year period.
Documents
Issuer
IMMUNE RESPONSE CORP
CIK 0000817785
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000817785
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 6:25 PM ET
- Size
- 5.6 KB